PFIZER INC.
- Country
- 🇺🇸United States
- Ownership
- Public
- Established
- 1849-01-01
- Employees
- 88K
- Market Cap
- $163.3B
- Website
- http://www.pfizer.com
Korean Regulatory Post Marketing Surveillance for Somavert
- First Posted Date
- 2021-11-23
- Last Posted Date
- 2025-02-14
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 100
- Registration Number
- NCT05131100
- Locations
- 🇰🇷
Pfizer, Seoul, Korea, Republic of
Food Effect Study to Evaluate the Effect of High-Fat Meal on the Relative Bioavailability of PF-07321332 Boosted With Ritonavir in Healthy Adult Participants
- Conditions
- Healthy Participants
- Interventions
- First Posted Date
- 2021-11-22
- Last Posted Date
- 2023-10-05
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 12
- Registration Number
- NCT05129475
- Locations
- 🇺🇸
New Haven Clinical Research Unit, New Haven, Connecticut, United States
A Target Occupancy Study With Ritlecitinib.
- First Posted Date
- 2021-11-19
- Last Posted Date
- 2023-11-13
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 16
- Registration Number
- NCT05128058
- Locations
- 🇺🇸
Pfizer Clinical Research Unit - New Haven, New Haven, Connecticut, United States
Assessment of the Effectiveness and Safety Outcome in Patients With Atrial Fibrillation Treated by Apixaban in Belgium
- Conditions
- Atrial Fibrillation
- First Posted Date
- 2021-11-10
- Last Posted Date
- 2023-05-17
- Lead Sponsor
- Pfizer
- Registration Number
- NCT05116267
- Locations
- 🇧🇪
Pfizer Site, Brussels, Belgium
Continuation Study of Long-term Safety, Tolerability, Pharmacokinetics and Efficacy of Recifercept in Achondroplasia
- Conditions
- Achondroplasia
- Interventions
- Biological: Recifercept
- First Posted Date
- 2021-11-10
- Last Posted Date
- 2024-02-08
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 35
- Registration Number
- NCT05116046
- Locations
- 🇺🇸
Long Beach Memorial Medical Center, Long Beach, California, United States
🇺🇸Nemours Children's Hospital, Delaware, Wilmington, Delaware, United States
🇦🇺Murdoch Children's Research Institute, Parkville, Victoria, Australia
A Study of PF-07258669 In Healthy Adult Participants
- Conditions
- Healthy Participants
- Interventions
- First Posted Date
- 2021-11-09
- Last Posted Date
- 2024-10-24
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 120
- Registration Number
- NCT05113940
- Locations
- 🇧🇪
Pfizer Clinical Research Unit - Brussels, Brussels, Bruxelles-capitale, Région DE, Belgium
Evaluation of the Pharmacokinetics, Safety and Tolerability of Single Dose of PF-06480605 in Chinese Healthy Participants
- Conditions
- Inflammatory Bowel Disease
- Interventions
- Drug: 450mgDrug: 150mgDrug: Placebo
- First Posted Date
- 2021-11-04
- Last Posted Date
- 2024-03-21
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 12
- Registration Number
- NCT05107492
- Locations
- 🇨🇳
Peking University Third Hospital, Beijing, Beijing, China
Study to Evaluate the Effect of Multiple-Dose Ritlecitinib on the Pharmacokinetics (PK) of Tolbutamide
- First Posted Date
- 2021-10-28
- Last Posted Date
- 2023-10-06
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 12
- Registration Number
- NCT05097716
- Locations
- 🇺🇸
New Haven Clinical Research Unit, New Haven, Connecticut, United States
Clinical Lot Consistency for RSVpreF in a Population of Healthy Adults 18 to ≤49 Years of Age
- Conditions
- RSV
- Interventions
- Biological: RSVpreF (Group 1)Biological: RSVpreF (Group 3)Biological: RSVpreF (Group 2)Biological: Placebo
- First Posted Date
- 2021-10-27
- Last Posted Date
- 2023-04-12
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 1028
- Registration Number
- NCT05096208
- Locations
- 🇺🇸
Precision Clinical Research, Sunrise, Florida, United States
🇺🇸Velocity Clinical Research, Providence, East Greenwich, Rhode Island, United States
🇺🇸East-West Medical Research Institute, Honolulu, Hawaii, United States
STUDY TO EVALUATE THE EFFECT OF PF-06882961 ON SINGLE DOSE ATORVASTATIN, MEDAZOLAM AND ORALCONTRACEPTIVE PHARMACOKINETICS IN HEALTHY ADULT PARTICIPANTS
- Conditions
- Healthy Adults
- Interventions
- First Posted Date
- 2021-10-26
- Last Posted Date
- 2024-08-19
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 35
- Registration Number
- NCT05093205
- Locations
- 🇺🇸
Anaheim Clinical Trials, LLC, Anaheim, California, United States